Article

Mmarketwatch.com on 2020-03-10 16:03

Novavax stock rises on funding for COVID-19 vaccine trial

Shares of Novavax Inc. were up 8% in trading on Tuesday after the company said it had received $4 million from the Coalition for Epidemic Preparedness ...

Stanley Erck

Related news

MNovavax stock rises on funding for COVID-19 vaccine trial marketwatch.com
MNovavax stock rises as it announces vaccine manufacturing deal with Endo marketwatch.com
Rochester
BNovavax Stock Soars on New Funding for Covid-19 Vaccine barrons.com
Germany , Japan , United Kingdom , Canada , Australia
BNovavax Stock Jumps on Final Data From U.K. Vaccine Trial barrons.com
South Africa , Ducey
BNovavax Stock Is Soaring on Covid-19 Vaccine Trials barrons.com
Australia , Phase 1 , Stock Island
PNovavax vaccine up to 96% effective in UK trial pendect.com
United States , United Kingdom
How the Novavax Covid-19 vaccine works CNN
South Africa , United Kingdom , Mexico , Texas , North Carolina
Chapel Hill startup targets seed funding after working to diversify Novavax Covid-19 vaccine trial bizjournals.com
Novavax stock soars after start of late-stage COVID-19 vaccine trial New York Post
Europe , United Kingdom
MNovavax stock drops as wider-than-expected loss overshadows vaccine booster data1 min read marketwatch.com
Philippines , Indonesia , India
Novavax COVID-19 vaccine hits 90% efficacy in large US trial newatlas.com
United States , United Kingdom , Mexico
BNovavax Stock Tumbles as Vaccine Delays Mount barrons.com
Mexico , Maryland
Gaithersburg's Novavax begins Phase 1 Ebola vaccine trials bizjournals.com
China , Guinea , Australia , Middle East , Phase 1
Novavax says Covid-19 vaccine is 89% effective in UK trial, but less so in South Africa CNN
Australia , Phase 1 , Mexico , United States , Oxford
Coronavirus vaccine: Novavax begins h...expressandstar.com
Australia , Phase 1 , Brisbane , Melbourne , Australia
MInovio's stock jumps on funding for vaccine trial in South Korea marketwatch.com
China , Phase 1 , South Korea
InnovationRx: Healthtech Funding Halftime Report; Plus, Novavax Vaccine EUA Forbes
France , Sano-shi , Palo Alto , Ukraine
TNovavax Stock Plummets After Slashing 2022 Vaccine Sales Forecast thestreet.com
United States